Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: A Canadian Thoracic Society clinical practice guideline

Alpha-1 Antitrypsin Deficiency Detection in a Portuguese Population

American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach

¿El déficit de alfa1 antitripsina es el culpable?

Déficit de alfa 1 antitripsina en pacientes con EPOC: estudio de corte transversal 

Diagnóstico y tratamiento del déficit de alfa-1-antitripsina

Inhaled AAT Phase II/III Update of Study Results

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult

Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015

Novel Therapeutic Uses of Alpha-1 Antitrypsin: A Window to the Future

Normativas de diagnóstico y tratamiento del déficit de alfa-1 antitripsina Asociación Argentina de Medicina Respiratoria 

Intravenous augmentation treatment and lung density in severe a1 antitrypsin defi ciency (RAPID): a randomised, double-blind, placebo-controlled trial

http://www.aamr.org.ar  

http://www.separ.eshttp://www.redaat.es   http://www.orphanet.es 

http://www.alfa1.org.es 

Arch Bronconeumol. 2010;46(Supl 4):2-8
 
Can Respir J Vol 19 No 2 March/April 2012

Am J Respir Crit Care Med Vol 168. pp 818–900, 2003

N Engl J Med 2009; 360:2749-57.

FEBS Journal 278 (2011) 3859–3867